In June, 2025, the Wellcome Trust announced an ambitious £10 million UK project called the Synthetic Human Genome Project (SynHG) and claimed it “will unlock a deeper understanding of life, leading to ...

Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.

Recreating a tiger is just the first step in Professor Pask's plans. He ultimately hopes to produce a healthy, sustainable ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

Back in early 2023, the dodo's genome was sequenced from a DNA sample. Now the company trying to resurrect the long-extinct ...

Scientists have uncovered a 400-million-year-old genetic secret that gave spiders the ability to produce silk and weave their webs. Spiders didn't begin their journey on Earth in the same way as they ...

Lilly and German biotech Seamless Therapeutics will develop recombinase-based treatments for hearing loss.

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...

Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for Duchenne muscular dystrophy (DMD) treatment. While adeno-associated virus ...

A landmark Huntington's trial slows disease progression by 75%, signalling how RNA- and CRISPR-based tools redefine treatment for rare genetic disorders. Significant advancements in gene silencing and ...